This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Estrup, T. M Articles by Strandgaard, S. Search for Related Content PubMed PubMed Citation Articles by Estrup, T. M Articles by Strandgaard, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Social Bookmarking                         What's this?

No effect of angiotensin II AT2-receptor antagonist PD 123319 on cerebral blood flow autoregulation

Neurobiology Research Unit, Rigshospitalet

Olaf B Paulson

Neurobiology Research Unit, Rigshospitalet, paulson{at}nru.dk

Svend Strandgaard

Department of Nephrology, Herlev Hospital, Copenhagen University Hospitals, Denmark

Blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin AT₁-receptor antagonists shift the limits of autoregulation of cerebral blood flow (CBF) towards lower blood pressure (BP). The role of AT₂-receptors in the regulation of the cerebral circulation is uncertain. Hence, the present study investigated the effect on CBF autoregulation of blocking of angiotensin AT₂-receptors with PD 123319 in spontaneously hypertensive rats (SHR). Anaesthetised and ventilated SHR were given PD 123319, 0.36 mg/kg/min, intravenously, and compared with a control group. CBF was measured by the intracarotid ^133-xenon injection method and BP was raised by noradrenaline infusion and lowered by controlled haemorrhage in separate groups of rats. The limits of autoregulation were determined by computed least-sum-of-squares analysis. PD 123319 did not influence baseline CBF, but resulted in a minor BP decrease (10 control and 10 treated rats). The lower limit of CBF autoregulation (eight treated and eight control) as well as the upper limit of CBF autoregulation (eight treated and eight control) were not significantly different in PD 123319 and control animals (lower limit treated 102±4 mmHg and control 94±4; NS, and upper limit treated 171±10 mmHg and control 162±7; NS). These findings indicate that acute AT₂-receptor blockade does not influence CBF autoregulation.

Key Words: angiotensin II • angiotensin II receptor antagonist • autoregulation • cerebral blood flow • PD 123319 • hypertension

Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 3, 188-192 (2001)
DOI: 10.3317/jraas.2001.026


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. F. Pedersen, O. B. Paulson, A. H. Nielsen, and S. Strandgaard Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1097 - H1104. [Abstract] [Full Text] [PDF]